Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis
Authors:
- Amanda B. PayneAPAmanda B. Payne
- Steph Battan-WraithSBSteph Battan-Wraith
- Elizabeth A.K. RowleyERElizabeth A.K. Rowley
- Melissa S. StockwellMSMelissa S. Stockwell
- Sara Y. TartofSTSara Y. Tartof
- Kristin DascombKDKristin Dascomb
- Stephanie A. IrvingSIStephanie A. Irving
- Brian DixonBDBrian Dixon
- Sarah W. BallSBSarah W. Ball
- Mark W. TenfordeMTMark W. Tenforde
- Gabriela Vazquez-BenitezGVGabriela Vazquez-Benitez
- Ashley B. StephensASAshley B. Stephens
Open Access
- 6 August 2025
- journal article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 49
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention (75D30121D12779)
- Centers for Disease Control and Prevention (75D30123C18039)
This publication has 38 references indexed in Scilit:
- Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial VirusJAMA Network Open, 2025
- RSV immunization uptake among infants and pregnant persons — Wisconsin, October 1, 2023-March 31, 2024Vaccine, 2025
- Real-world effectiveness of nirsevimab immunisation against bronchiolitis in infants: a case–control study in Paris, FranceThe Lancet Child & Adolescent Health, 2024
- Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessmentVaccine, 2024
- Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studyThe Lancet Infectious Diseases, 2024
- Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term InfantsNew England Journal of Medicine, 2022
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsNew England Journal of Medicine, 2021
- Single-Dose Nirsevimab for Prevention of RSV in Preterm InfantsNew England Journal of Medicine, 2020
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenNew England Journal of Medicine, 2009
- The effect of misclassification on evaluating the effectiveness of influenza vaccinesVaccine, 2008